Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-05-09-Speech-3-208-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-05-09"^^xsd:date2
dcterms:Is Part Of	lp_eu:Patenting of essential biological processes (debate)2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20120509.21.3-208-000"2
lpv:hasSubsequent	lp_eu:2012-05-09-Speech-3-209-0002
lpv:speaker	lp:João Ferreira2
lpv:spokenAs	member; Delegation to the EU-Former Yugoslav Republic of Macedonia Joint Parliamentary Committee (2009-09-16--2013-02-03)3 unknown; Partido Comunista Português (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the countries of the Andean Community (2009-09-16--2014-06-30)3 vice-chair; EUL/NGL (2012-02-07--2014-06-30)3 member; PECH (2012-01-19--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; ENVI (2012-01-19--2014-06-30)3 substitute; BUDG (2012-01-19--2014-06-30)3
lpv:translated text	"Mr President, in recent months, more than 70 000 people and nearly 300 organisations have given powerful expression to a campaign against the patenting of seeds. This broad-based movement, rooted in various national campaigns, has drawn attention to the way in which the legislation on patents in the European Union has been implemented, in that it paves the way for the patenting of plants and animals, genetic material and essential biological processes: in other words, life itself. This unacceptable path has led, for example, to the creation of genuine monopolies in the production processes of the agriculture sector. Two multinationals control and divide up the market between themselves at the cost of ruining many small and medium-sized producers and reducing product diversity and consumer choice. The ethical, social and political implications of this issue are far-reaching. For this reason, we applaud the citizens and organisations that have taken part in this campaign. It is one thing to invent genetic transformation processes by using molecular biology, but the product – the living organisms created by such technologies – is something different. It is not acceptable for there to be intellectual property rights over these organisms, just as it is not acceptable for there to be patenting of conventional genetic selection processes, cross-breeding processes or selected products of such cross-breeding, such as new varieties of plants and animals, or laboratory-assisted selection processes where entire genomes are involved. From that point of view, this regulation introduces some clarity where it was needed."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph